{"title":"The Effect of GLUT-1-XbaI G>T and HaeIII T>C Polymorphisms on <sup>18</sup>F-FDG Uptake Rates.","authors":"Melih Kısaarslan, Yasemin Adalı, Veli Kaan Aydın, Yasemin Berberoğlu, Doğangün Yüksel, Aylin Köseler","doi":"10.4274/mirt.galenos.2025.93797","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the effects of glut polymorphisms on <sup>18</sup>Fluorine-fluorodeoxyglucose (<sup>18</sup>F-FDG) uptake rates.</p><p><strong>Methods: </strong>The <sup>18</sup>F-FDG positron emission tomography/computed tomography images and mass lesion metabolism standard uptake value maximum (SUV<sub>max</sub>) results of the patients were evaluated. Glucose transporter protein-1 (GLUT-1)-XbaI G>T (rs2754218) and HaeIII T>C (rs1385129) polymorphisms and their effects on <sup>18</sup>F-FDG uptake rates were investigated using DNA obtained from peripheral blood.</p><p><strong>Results: </strong>When the Xbal G>T genotype distribution of the patients was examined, the Xbal G/G genotype was found to be 87%, the Xbal G/T genotype 12%. The XbaI T/T phenotype was detected in only one patient (1%). In the HaeIII T>C genotype distribution, the HaeIII C/C genotype was found as 54%, the HaeIII T/C genotype as 31%, and the HaeIII T/T genotype as 15%. When the Xbal and HaeIII genotypes were examined together, the number of polymorphic genotypes was significantly higher in the lung and bronchial tumor groups compared to other cancer types.</p><p><strong>Conclusion: </strong>The presence of polymorphism in at least one of the two gene regions, in the lung-bronchial tumor group and the high SUV<sub>max</sub> value in this patient group, may indicate a change in the involvement rates.</p>","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":"34 2","pages":"90-96"},"PeriodicalIF":1.1000,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12134951/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Imaging and Radionuclide Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/mirt.galenos.2025.93797","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: To investigate the effects of glut polymorphisms on 18Fluorine-fluorodeoxyglucose (18F-FDG) uptake rates.
Methods: The 18F-FDG positron emission tomography/computed tomography images and mass lesion metabolism standard uptake value maximum (SUVmax) results of the patients were evaluated. Glucose transporter protein-1 (GLUT-1)-XbaI G>T (rs2754218) and HaeIII T>C (rs1385129) polymorphisms and their effects on 18F-FDG uptake rates were investigated using DNA obtained from peripheral blood.
Results: When the Xbal G>T genotype distribution of the patients was examined, the Xbal G/G genotype was found to be 87%, the Xbal G/T genotype 12%. The XbaI T/T phenotype was detected in only one patient (1%). In the HaeIII T>C genotype distribution, the HaeIII C/C genotype was found as 54%, the HaeIII T/C genotype as 31%, and the HaeIII T/T genotype as 15%. When the Xbal and HaeIII genotypes were examined together, the number of polymorphic genotypes was significantly higher in the lung and bronchial tumor groups compared to other cancer types.
Conclusion: The presence of polymorphism in at least one of the two gene regions, in the lung-bronchial tumor group and the high SUVmax value in this patient group, may indicate a change in the involvement rates.
期刊介绍:
Molecular Imaging and Radionuclide Therapy (Mol Imaging Radionucl Ther, MIRT) is publishes original research articles, invited reviews, editorials, short communications, letters, consensus statements, guidelines and case reports with a literature review on the topic, in the field of molecular imaging, multimodality imaging, nuclear medicine, radionuclide therapy, radiopharmacy, medical physics, dosimetry and radiobiology.